Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir T Fathi

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|December 22, 2012
Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to boneHossein Sadrzadeh, Amelia E Huck, Yi-Bin Chen, et al.
Leukemia & Lymphoma|July 10, 2015
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER databaseAndrew M Brunner, Gabriela Hobbs, Marla M Jalbut, et al.
American Journal of Clinical Pathology|January 22, 2017
Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell TransplantationAlexandra E Kovach, Andrew M Brunner, Amir T Fathi, et al.
Blood|May 21, 2013
FLT3 inhibitor-induced neutrophilic dermatosisAmir T Fathi, Long Le, Robert P Hasserjian, et al.
The New England Journal of Medicine|December 14, 2016
Case 37-2016. An 86-Year-Old Woman with Leukocytosis and SplenomegalyAmir T Fathi, Timothy A Graubert, Naveen M Kulkarni, et al.
Leukemia Research|July 30, 2015
Prior cytopenia predicts worse clinical outcome in acute myeloid leukemiaAmelia Huck, Olga Pozdnyakova, Andrew Brunner, et al.
Experimental Hematology|December 17, 2013
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutationsAshkan Emadi, Sung Ah Jun, Takashi Tsukamoto, et al.
Leukemia & Lymphoma|January 23, 2024
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignanciesEytan M Stein, Amir T Fathi, Wael A Harb, et al.
Histopathology|July 23, 2022
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemiaMegan J Fitzpatrick, Leonardo Boiocchi, Amir T Fathi, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|December 22, 2012
Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to boneHossein Sadrzadeh, Amelia E Huck, Yi-Bin Chen, et al.
Leukemia & Lymphoma|July 10, 2015
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER databaseAndrew M Brunner, Gabriela Hobbs, Marla M Jalbut, et al.
American Journal of Clinical Pathology|January 22, 2017
Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell TransplantationAlexandra E Kovach, Andrew M Brunner, Amir T Fathi, et al.
Blood|May 21, 2013
FLT3 inhibitor-induced neutrophilic dermatosisAmir T Fathi, Long Le, Robert P Hasserjian, et al.
The New England Journal of Medicine|December 14, 2016
Case 37-2016. An 86-Year-Old Woman with Leukocytosis and SplenomegalyAmir T Fathi, Timothy A Graubert, Naveen M Kulkarni, et al.
Leukemia Research|July 30, 2015
Prior cytopenia predicts worse clinical outcome in acute myeloid leukemiaAmelia Huck, Olga Pozdnyakova, Andrew Brunner, et al.
Experimental Hematology|December 17, 2013
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutationsAshkan Emadi, Sung Ah Jun, Takashi Tsukamoto, et al.
Leukemia & Lymphoma|January 23, 2024
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignanciesEytan M Stein, Amir T Fathi, Wael A Harb, et al.
Histopathology|July 23, 2022
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemiaMegan J Fitzpatrick, Leonardo Boiocchi, Amir T Fathi, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Pageof 18